The University of Massachusetts Medical School and the Carnegie Institution of Washington have announced that they have entered into licensing agreements with Oxford BioMedica (LSE: OXB), a gene therapy company, that grants the company rights to key RNA interference (RNAi) patent rights. The technology was invented by Nobel-prize winning scientists Andrew Z. Fire, PhD, and [...]